Informations sur le produit
- 5-Pyrimidinecarboxamide, 4-(cyclopropylamino)-2-[[4-[4-(ethylsulfonyl)-1-piperazinyl]phenyl]amino]-
- PRT 062070
- PRT 2017
- Cerdulatinib
- 4-(Cyclopropylamino)-2-[[4-[4-(ethylsulfonyl)-1-piperazinyl]phenyl]amino]-5-pyrimidinecarboxamide
Cerdulatinib (PRT2070) is an ester hydrochloride compound with antifibrotic properties. It has been shown to inhibit the growth and proliferation of fibroblasts, which play a key role in the development of fibrosis. Cerdulatinib works by targeting alpha-tocotrienol, nintedanib, sildenafil, and other nucleophilic compounds involved in fibrotic pathways. Additionally, it has been found to inhibit fatty acid synthesis and collagen production, further contributing to its anti-fibrotic effects. Research suggests that cerdulatinib may also modulate the activity of β-catenin, a protein involved in cell signaling pathways related to fibrosis. This compound shows promise as a potential therapeutic option for various fibrotic conditions.
Propriétés chimiques
Question d’ordre technique sur : 3D-YXB30079 Cerdulatinib (PRT2070)
Si vous souhaitez demander un devis ou passer commande, veuillez plutôt ajouter les produits souhaités à votre panier, puis demander un devis ou passer commande à partir de votre panier. C'est une méthode plus rapide, plus économique, et vous pourrez bénéficier des remises disponibles ainsi que d'autres avantages
